This page follows insider dealings at Notable Labs, Ltd. as filed with SEC (Form 4), a company from the Health Care sector. Notable Labs, Ltd. has had no insider filing for more than a year; the last one goes back to 10 May 2024.
Over the whole record (from 2023), the tally stands at no purchases and 4 sales.
For comparison within the same sector, see the insider buying recorded at Xenon Pharmaceuticals Inc. and Vivos Inc. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
FY ended December 2023 · cache
11 of 11 declarations
Notable Labs, Ltd. is a company listed on the XNAS market, focused on developing research solutions for cancer treatment. It utilizes advanced technologies to enhance patient outcomes.
Purchases our model currently ranks for the recommendations list.
All recommendations| Fiscal year end | Revenue | Net income | Diluted EPS | Filing |
|---|---|---|---|---|
| Dec 2023 | 310,000 USD | -11.3 m USD | -3.41 USD | 10-K |
| Dec 2022 | 8,000 USD | -14.4 m USD | -21.97 USD | 10-K |
| Dec 2021 | 768,000 USD | -29.9 m USD | n.d. | 10-K |
| Dec 2020 | 922,000 USD | -24.2 m USD | n.d. | 20-F |
| Dec 2019 | 562,000 USD | -19.4 m USD | n.d. | 20-F |
Amounts in USD, as filed (forms 10-K, 20-F or 40-F). Source: SEC EDGAR.